Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to ...

Delayed esophageal transit on scintigraphy among patients with SSc is linked to a more severe disease phenotype.

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by widespread vascular abnormalities, immune system activation, and skin and internal ...

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

Gastroesophageal reflux disease (GERD) is associated with more severe interstitial lung disease (ILD) in systemic sclerosis (SSc), according to study findings published in Rheumatology.

A new study validates the Scleroderma Skin Questionnaire (SSQ) as a reliable tool for assessing skin symptoms in systemic ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

Systemic sclerosis appears to have a “non-random” occurrence across the United States, with clusters of people diagnosed ...

Systemic lupus erythematosus, or lupus, is a complex autoimmune disease in which the immune system mistakenly attacks healthy ...

Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

New research recommends that clinicians screen for foot peripheral sensory neuropathy during initial assessments for patients with systemic sclerosis.